Sequana Medical NV SEQUA-BE:Euronext Brussels

*Data is delayed | EUR
Last | 1:50 PM CEST
5.66quote price arrow up+0.02 (+0.35%)
Volume
1,137
52 week range
5.26 - 9.80
Loading...
  • Open5.60
  • Day High5.76
  • Day Low5.60
  • Prev Close5.64
  • 52 Week High9.80
  • 52 Week High Date06/18/21
  • 52 Week Low5.26
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap110.63M
  • Shares Out18.58M
  • 10 Day Average Volume5,022.6
  • Dividend-
  • Dividend Yield-
  • Beta0.7
  • YTD % Change-25.13

KEY STATS

  • Open5.60
  • Day High5.76
  • Day Low5.60
  • Prev Close5.64
  • 52 Week High9.80
  • 52 Week High Date06/18/21
  • 52 Week Low5.26
  • 52 Week Low Date05/12/22
  • Market Cap110.63M
  • Shares Out18.58M
  • 10 Day Average Volume5,022.6
  • Dividend-
  • Dividend Yield-
  • Beta0.7
  • YTD % Change-25.13

RATIOS/PROFITABILITY

  • EPS (TTM)-1.30
  • P/E (TTM)-4.35
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sequana Medical NV

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sequana Medical NV is a Belgium-based company, which manufactures medical devices. The Company focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant...
Pierre Chauvineau
Non-Executive Independent Chairman of the Board
Ian Crosbie
Chief Executive Officer, Executive Director
Kirsten Van Bockstaele
Chief Financial Officer
Dirk Fengels
Global Vice President Engineering and Manufacturing
Timur Resch
Global Vice President Quality Management and Regulatory Affairs
Address
Technologiepark 122, Zwijnaarde
Gent
9052
Belgium